Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127876741 | 12787674 | 1 | I | 20160818 | 20160922 | 20160928 | 20160928 | PER | US-GLAXOSMITHKLINE-US2016GSK140151 | GLAXOSMITHKLINE | 0.00 | M | Y | 0.00000 | 20160928 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127876741 | 12787674 | 1 | PS | ARNUITY ELLIPTA | FLUTICASONE FUROATE | 1 | Respiratory (inhalation) | 1 PUFF(S), 1D | 3 | DF | Y | UNKNOWN | 205625 | 1 | DF | INHALATION POWDER | QD | ||
| 127876741 | 12787674 | 2 | SS | FLOVENT | FLUTICASONE PROPIONATE | 1 | Respiratory (inhalation) | 1 PUFF(S), BID | U | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127876741 | 12787674 | 1 | Chronic obstructive pulmonary disease |
| 127876741 | 12787674 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127876741 | 12787674 | Chest pain | |
| 127876741 | 12787674 | Drug dose omission |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127876741 | 12787674 | 1 | 20160815 | 20160818 | 0 |